Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CAMPBELL'S CoCPB · Entity 3700 | Director · President and CEO | September 30, 2017 | October 03, 2017 |
| METLIFE INCMET · Entity 488 | Director | April 01, 2026 | April 03, 2026 |
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | Director | May 20, 2026 | May 21, 2026 |
| VISA INC.V · Entity 495 | Director | January 27, 2026 | January 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CAMPBELL'S Co
Report date September 30, 2017 · Filed October 03, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 386,672 |
Ending reported balance
After 2017-09-30 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2017-09-30 · Tax withholding · Disposed 66,970 · Balance 341,281 Row 2 · 2017-09-30 · Grant · Acquired 20,559 · Balance 361,840 F1: On October 1, 2014, the Reporting Person was granted 82,238 RSUs that were subject to both performance-vesting and service-vesting requirements; the number of shares underlying these RSUs were reported on Form 4 at the time of grant at the target amount. Based on the level at which the performance goals were attained, the October 1, 2014 RSU grant vested at 125% on September 30, 2017, resulting in the Reporting Person receiving the additional shares reported above. Row 3 · 2017-09-30 · Grant · Acquired 24,832 · Balance 386,672 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.19 · Expires 2027-10-01 | Direct | 207,468 |
Reported balance
After 2017-10-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-10-01 · Grant · Acquired 207,468 · Balance 207,468 F3: The options will vest in equal installments on each of the first three anniversaries of the Grant Date. |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 1,165.27 |
Reported balance
Holding disclosure · report date 2017-09-30 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,165.27 F2: Represents routine transactions under the issuer's 401(k) Plan since the date of the reporting person's last report. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 1, 2014, the Reporting Person was granted 82,238 RSUs that were subject to both performance-vesting and service-vesting requirements; the number of shares underlying these RSUs were reported on Form 4 at the time of grant at the target amount. Based on the level at which the performance goals were attained, the October 1, 2014 RSU grant vested at 125% on September 30, 2017, resulting in the Reporting Person receiving the additional shares reported above.
F2: Represents routine transactions under the issuer's 401(k) Plan since the date of the reporting person's last report.
F3: The options will vest in equal installments on each of the first three anniversaries of the Grant Date.
METLIFE INC
Report date April 01, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,711 |
Reported balance
After 2026-04-01 transaction · row 1
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 721 · Balance 34,711 F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.
QUEST DIAGNOSTICS INC
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,929 |
Reported balance
After 2026-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,142 · Balance 11,929 F1: Represents an award of restricted stock units. F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units.
F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
VISA INC.
Report date January 27, 2026 · Filed January 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 10,133 |
Reported balance
After 2026-01-27 transaction · row 1
1 source rowRow 1 · 2026-01-27 · Grant · Acquired 861 · Balance 10,133 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 21, 2026 20:53 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001230166-26-000008 · wk-form4_1779396782.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,929 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:04 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 721 | $0.00 | $0.00 |
DisclosureSEC source: 0001230166-26-000006 · wk-form4_1775246689.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,711 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 22:16 UTC | VISA INC. V · Entity 495 | GrantClass A Common Stock | 861 | $0.00 | $0.00 |
DisclosureSEC source: 0001403161-26-000036 · form4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,133 Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:10 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 639 | $0.00 | $0.00 |
DisclosureSEC source: 0001230166-26-000003 · wk-form4_1767733841.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,990 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:02 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 534 | $0.00 | $0.00 |
DisclosureSEC source: 0001230166-25-000004 · wk-form4_1759521723.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,351 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:33 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 562 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-25-000182 · wk-form4_1750451573.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,817 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:22 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000145 · wk-form4_1747686114.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,742 F1 · security: Represents an award of restricted stock units. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:28 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 540 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-25-000118 · wk-form4_1743712110.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,255 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 22:29 UTC | VISA INC. V · Entity 495 | GrantClass A Common Stock | 777 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-002323 · form4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,272 Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:40 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-25-000030 · wk-form4_1736199644.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,715 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:16 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000246 · wk-form4_1727986582.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,180 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:37 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 627 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000181 · wk-form4_1718915836.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,645 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| May 16, 2024 Filed May 20, 2024 23:16 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-24-000117 · wk-form4_1716246998.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,490 F1 · security: Represents an award of restricted share units. F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 20:23 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 594 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000125 · wk-form4_1712175766.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,018 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 23:01 UTC | VISA INC. V · Entity 495 | GrantClass A Common Stock | 958 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-002058 · form4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,495 Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:36 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000018 · wk-form4_1704404157.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,424 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:36 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000259 · wk-form4_1696451757.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,774 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 20:19 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 803 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000197 · wf-form4_168746515301298.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,064 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:15 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-23-000109 · wk-form4_1684534493.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,955 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 21:03 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 755 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000134 · wf-form4_168072859831718.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,261 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:04 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 31 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000091 · wf-form4_167780185319289.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,506 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 23:59 UTC | VISA INC. V · Entity 495 | GrantClass A Common Stock | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-002381 · form4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,511 Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:27 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-23-000026 · wf-form4_167295403363378.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,475 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 20:26 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 599 | $62.62 | $37,509.38 |
DisclosureSEC source: 0001099219-22-000159 · wf-form4_166500157025181.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,955 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:15 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 600 | $62.53 | $37,518.00 |
DisclosureSEC source: 0000937834-22-000082 · wf-form4_165601529895465.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,356 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 09, 2022 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 3 | $210.92 | $632.77 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 17 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,487 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000090 · wf-form4_165307852380808.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,540 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes approximately 42 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:10 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 532 | $70.50 | $37,506.00 |
DisclosureSEC source: 0001099219-22-000095 · wf-form4_164918940008015.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,756 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| February 03, 2022 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 3 | $232.40 | $697.20 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 16 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,484 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| February 01, 2022 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 3 | $231.10 | $693.30 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 15 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,481 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| January 25, 2022 Filed Jan 28, 2022 01:12 UTC | VISA INC. V · Entity 495 | GrantClass A Common Stock | 1,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-002327 · form4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,461 Read SEC document |
| January 19, 2022 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 3 | $216.37 | $649.10 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 14 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,364 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:42 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 594 | $63.23 | $37,558.62 |
DisclosureSEC source: 0000937834-22-000020 · wf-form4_164141895667153.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,224 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| December 17, 2021 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 14 | $212.75 | $2,978.52 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 13 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,361 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:25 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 600 | $62.52 | $37,512.00 |
DisclosureSEC source: 0001099219-21-000319 · wf-form4_163346550378084.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,630 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:20 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 589 | $63.77 | $37,560.53 |
DisclosureSEC source: 0001099219-21-000249 · wf-form4_162396475468908.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,030 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| May 25, 2021 Filed May 25, 2021 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000089 · wf-form4_162197500311313.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,206 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:00 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 609 | $61.60 | $37,514.40 |
DisclosureSEC source: 0001099219-21-000162 · wf-form4_161765631955765.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,441 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 26, 2021 Filed Jan 27, 2021 23:14 UTC | VISA INC. V · Entity 495 | GrantClass A Common Stock | 1,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002755 · form4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,347 Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:32 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 814 | $46.08 | $37,509.12 |
DisclosureSEC source: 0001099219-21-000032 · wf-form4_160988234947230.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,832 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 21:41 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 1,007 | $37.26 | $37,520.82 |
DisclosureSEC source: 0001099219-20-000351 · wf-form4_160193402743061.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,018 F1 · kind: The reporting person acquired these shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| August 06, 2020 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | SaleClass A Common Stock | 452 | $195.12 | $88,195.82 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 12 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,283 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.1232 to $195.1243 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:52 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 970 | $38.69 | $37,529.30 |
DisclosureSEC source: 0001099219-20-000276 · wf-form4_159251355097739.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,011 F1 · kind: The reporting person acquired these shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000121 · wf-form4_159009326198434.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,783 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 20, 2020 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 42 | $165.73 | $6,960.61 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 11 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,735 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 21:20 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 1,345 | $27.90 | $37,525.50 |
DisclosureSEC source: 0001099219-20-000178 · wf-form4_158586240644007.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,041 F1 · kind: The reporting person acquired these shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| March 19, 2020 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | SaleClass A Common Stock | 31 | $154.84 | $4,800.08 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 10 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,693 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| January 28, 2020 Filed Jan 29, 2020 21:33 UTC | VISA INC. V · Entity 495 | GrantClass A Common Stock | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-002634 · form4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,283 Read SEC document |
| January 16, 2020 Filed Feb 17, 2023 21:15 UTC | VISA INC. V · Entity 495 | PurchaseClass A Common Stock | 131 | $200.56 | $26,273.91 |
DisclosureSEC source: 0001127602-23-005832 · form4.xml · nonDerivative · entry 9 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,664 F1 · balance_after: The amount of shares reported as beneficially owned by the Reporting Person as of each applicable date set forth herein reflects the number of shares owned by the Reporting Person as of such applicable date, after giving effect to the transactions reported herein as of such date and those transactions reported herein prior to such date. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:51 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000047 · wf-form4_157834747874883.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,696 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.